Market Overview

Oncolytics Closes Offering of 8M Shares at $4/Share for Gross Proceeds of $32M

Related ONCY
Oncolytics Biotech Announces Phase 1b Study in Advanced Pancreatic Cancer is Now Active
Oncolytics Biotech Collaborators to Present Survival Data from REO 016 Study in NCLC at IASLC

Oncolytics Biotech Inc. (NASDAQ: ONCY) announced today that it has closed its previously announced underwritten public offering of 8.0 million common shares, at a public offering price of US$4.00 per common share.  The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Oncolytics, were approximately US$32.0 million.

Posted-In: News Offerings


Related Articles (ONCY)

Get Benzinga's Newsletters